Clinical Trials in San Antonio

Showing 7841-7860 of 11,125 trials

A Study to Evaluate the Food-Effect of H3B-6527

NCT03424577

This study will be conducted to determine the effect of food on the relative bioavailability of H3B-6527 following administration of a H3B-6527 capsule with and without a meal.

Healthy Participants

Eisai Inc.17 participantsStarted Dec 2017

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

NCT00877006

The primary objective of the study is to compare the complete response (CR) rate of bendamustine and rituximab (BR) with that of standard treatment regimens of either rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP) or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with advanced, indolent non-Hodgkin's lymphoma (NHL) or mantle cell lymphoma (MCL).

Non-Hodgkin's LymphomaMantle Cell Lymphoma

Teva Branded Pharmaceutical Products R&D, Inc.447 participantsStarted Apr 2009

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Corona, California, United States +125 more locations

A Study to Evaluate the Food-Effect of H3B-6527

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Find Trials by Condition in San Antonio

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Lesinurad and Febuxostat Combination Extension Study in Gout

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NOLAN: Naproxen or Loratadine and Neulasta

Effectiveness of Aurix Therapy in Pressure Ulcers

A Phase II Trial of Regadenoson in Sickle Cell Anemia

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

A Study of DCC-2701 in Participants With Advanced Solid Tumors

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

DNS-7801 vs. Placebo in Parkinson's Disease